Key result
FFR-guided PCI for stable CAD was associated with a significantly lower rate of death or myocardial infarction compared to angiography-guided PCI (HR 0.63).
Why the study?
Does an FFR-guided treatment strategy improve long-term clinical outcomes compared to an angiography-guided strategy in patients with stable coronary artery disease requiring PCI?
Population
1,716 patients with stable coronary artery disease and at least one 50-89% coronary stenosis thought to…
Comparison
Fractional flow reserve-guided treatment strategy vs Angiography (XA)-guided treatment strategy
Design
Cohort
Follow-up
4 years
Authors
Loading...
FFR adoption varies in stable CAD PCI; leaves open whether it improves outcomes over angiography in routine practice.
Cohort (n=1,716)
Does an FFR-guided treatment strategy improve long-term clinical outcomes compared to an angiography-guided strategy in patients with stable coronary artery disease requiring PCI?
Hazard Ratio: 0.63
In daily clinical practice, FFR-guided PCI for stable CAD significantly reduces long-term rates of death, myocardial infarction, and target lesion revascularization compared to angiography guidance alone.
Backer et al. (2016) conducted a cohort in stable coronary artery disease (n=1,716). FFR-guided PCI vs. Angiography (XA)-guided PCI was evaluated on combined endpoint of death/MI (HR 0.63). FFR-guided PCI for stable CAD was associated with a significantly lower rate of death or myocardial infarction compared to angiography-guided PCI (HR 0.63).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: